Literature DB >> 30079003

Retrospective Genetic Analysis of 200 Cases of Sudden Infant Death Syndrome and Its Relationship with Long QT Syndrome in Korea.

Min-Jeong Son1, Min-Kyoung Kim1, Kyung-Moo Yang2, Byung-Ha Choi3, Bong Woo Lee3, Seong Ho Yoo1.   

Abstract

BACKGROUND: There has been a campaign by the National Education on Sleeping Habits and Living Environment, to reduce the incidence of sudden infant death syndrome (SIDS). However, more than 100 infants die suddenly and unexplainably before the age of 1 year in Korea. Long QT syndrome (LQTS), an inheritable cardiac disease, has been reported to likely be associated with up to 14% of SIDS cases. However, genetic studies of the association between SIDS and LQTS have not yet been conducted in Korea.
METHODS: We conducted genetic analysis using genomic DNA extracted from paraffin-embedded tissue blocks from 200 SIDS cases autopsied between 2005 and 2013. We analyzed the following genetic mutations associated with LQTS, KCNQ1, SCN5A, KCNE1, KCNE2, KCNJ2, and CAV3.
RESULTS: Of the 200 SIDS cases, 58% involved male infants (116 male and 84 female infants, respectively), the mean age was 140 days (median, 107 days; range, 24-270 days), and they were all of Asian-Korean ethnicity. SIDS IA category criteria comprised 45 cases (22.5%) while the rest were SIDS IB. Fifteen infants (7.5%) had R1193Q in SCN5A, of doubtful pathogenicity, and no pathogenic LQTS variants were observed.
CONCLUSION: This genetic investigation of LQTS in SIDS showed a low diagnostic yield. These findings suggest that LQTS molecular autopsy could be cautiously conducted in selected cases with family involvement to improve the available genetic counseling information. Meanwhile, a national SIDS registry should be established to document and evaluate the genetic risk of SIDS in Korea.

Entities:  

Keywords:  Genetic; Long QT Syndrome; Molecular Autopsy; Sudden Infant Death Syndrome

Mesh:

Year:  2018        PMID: 30079003      PMCID: PMC6070466          DOI: 10.3346/jkms.2018.33.e200

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


INTRODUCTION

Sudden unexplained infant deaths (SUIDs) are defined as the death of an infant less than 1-year-old in which investigation, autopsy, medical history review, and appropriate laboratory testing fail to identify a specific cause of death, which includes cases that meet the definition of sudden infant death syndrome (SIDS).1 We previously reviewed 355 cases of SIDS in Korea, focusing on the sleep environment.2 Subsequently, the campaign for safe sleep environments including “back to sleep” was widely launched but more than 100 infants still die suddenly and unexplainably before the age of 1 year in Korea. Long QT syndrome (LQTS) is a group of inheritable primary electric diseases of the heart. The disease cluster was first noted in a family where several children with congenital hearing loss exhibited QT prolongation in electrocardiography (ECG) examinations, and experienced recurrent syncope and sudden cardiac death, with an autosomal recessive inheritance (Jervelle and Lange-Nielsen [JLN] syndrome).3 LQTS is now understood to be a cardiac channelopathy involving ventricular repolarization delay due to a prolonged duration of the myocardial action potential. Postmortem genetic testing or molecular autopsy has revealed a strong association between LQTS variation and SIDS.45 It has been reported that 5.2%–14.0% of SIDS cases may be linked to LQTS,67 which affects the cardiac conduction system. Therefore, postmortem genetic testing has recently been recommended as a routine procedure in the autopsy of SIDS cases.68 Unfortunately, the molecular diagnosis of postmortem examinations is not yet a routine practice in Korea. In this study, we retrospectively reviewed 200 SIDS cases from a genetic viewpoint to determine the number of cases in Korea that may have been associated with LQTS variation and accumulate information to support the value of the availability of postmortem genetic testing for SIDS in Korea.

METHODS

We designed a retrospective study to test for the presence of genetic risk factors involving LQTS in SIDS in Korea. The cases analyzed were retrieved from a nationwide pool of infant deaths recorded between January 2005 and December 2013. After a thorough review of the police investigative and autopsy reports as well as a histological re-examination, 200 cases of SIDS IA and IB were selected according to Krous et al.9 The SIDS IA group was defined based on the following characteristics: cases aged 21 to 270 days at the time of death with a normal clinical history, term delivery, normal growth and development, no familial history of sudden unexplained deaths, and no suspicious scenes. A comprehensive postmortem investigation including toxicological, microbiological, vitreous chemistry, or metabolic screening studies with death scene investigation by police authorities was conducted. Category IB consisted of infant deaths that met the general definition as well as all the criteria for category IA except for this investigation. Infants of the SIDS category II, which includes deaths outside the SIDS I age range (21 days to 9 months) and cases where accidental asphyxia, were excluded in this study.9 The obtained data included the position in which the deceased was found. The genomic DNA from 200 SIDS patients was extracted from the organ (the heart or liver) tissue paraffin-embedded blocks using the QIAamp DNA FFPE tissue kit (QIAGEN, Hilden, Germany). Owing to expected low DNA yields from the paraffin-embedded tissue samples from each patient, all DNA quantities were determined using a NANODROP™ LITE spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA). Table 1 shows the 85 DNA variants from 6 genes (KCNQ1, SCN5A, KCNE1, KCNE2, KCNJ2, and CAV3), ascertained from the literature using PubMed (www.ncbi.nlm.nih.gov) based on their reported involvement in SIDS,1011121314151617181920 which were investigated using a real-time polymerase chain reaction (PCR) single nucleotide polymorphism (SNP) assay.
Table 1

LQT-related genes investigated in this study

GenesProtein changeMutation pointFrequency
CAV3T78Mc233t0
V14Lg40c0
T78Kc233a0
KCNH2G604Sg1825a0
G628Sg1882a0
R1047Lg3140t0
KCNQ1P117Lc350t0
E146Kg436a0
KCNE1G25Vg74t0
G60Dg179a0
SCN5AA997Dc2990a0
A997Sg2989t0
A997Tg2989a0
C1004Rt3010c0
D1041Ng3121a0
E1015Kg3043a0
E1784Kg5350a0
F1293St3878c0
F1473St4418c0
F1522Yt4565a0
F919Lc2757a0
G514Cg1540t0
G615Eg1844a0
G709Vg2126t0
G833Rg2497a0
G969Cg2905t0
H558Ra1673g36
I1005Tt3014c0
I1835Tt5504c0
I759Fa2275t0
K1018Ea3052g0
L1308Fc3922t0
L461Fg1383t0
L567Qt1700a0
L995Fc2983t0
N1325Sa3974g0
N1774Dc5302a0
N291Ha871c0
N406Kc1218a0
P1002Sc3004t0
P1008Sc3022t0
P1011Lc3032t0
P1011Sc3031t0
P1021Sc3061t0
P1090Lc3269t9
P648Lc1943t0
Q1000La2999t0
R1023Cc3067t0
R1023Hg3068a0
R1023Pg3068c0
R1193Qg3578a15
R1826Hg5474a0
R222Qg665a0
R367Hg1100a0
R620Hg1859a0
R680Hg2039a0
R689Cc2065t0
R689Hg2066a0
R811Hg2432a0
R975Wt2923c0
R986Qg2957a0
S1103Yc3308a0
S1218Ig3653t0
S1787Ng5360a0
S216Lc647t0
S524Yc1571a0
T1007Ic3020t0
T1016Mc3047t0
T1304mg5050a0
V1951Lg5870a0
V232Ig694a0
V411Mg1231a0
Y1494Nt4480a0
KCNJ2C54Fg161t0
R67Qg200a0
D71Ng211a0
T75Aa223g0
D78Yg232t0
R82Qg245a0
C101Rt301c0
G144Sg430a0
G146Sg436a0
T192Aa574g0
G215Dg644a0
R218Qg653a0

LQT = long QT.

LQT = long QT. The SNP genotyping with real-time PCR used a pair of primers and a specific dye-labeled probe for each allele: allele 1 (normal) was labeled with FAM, and the other allele 2 (mutation) was labeled with HEX. During amplification, the generation of FAM, HEX, or both types of fluorescence indicate an allele 1 homozygote, allele 2 homozygote, and a heterozygote, respectively. The quencher dye at the 3ʹ end of each probe was BHQ®-1 (black hole quencher® 1). Some primers and probes were designed firsthand whereas others were purchased from Applied Biosystems (AB) Taqman SNP assays mto human SM (Life Technologies, Carlsbad, CA, USA). Real-time PCR was performed with 20 ng gDNA using the iQ probe SuperMix and CFX Connect™ real-time PCR (Bio-Rad, Hercules, MA, USA) according to the manufacturer's protocol. The PCR conditions were as follows: an initial incubation at 95°C for 5 minutes, followed by 50 cycles of denaturation at 95°C for 15 seconds and annealing and extension at 60°C–68°C (temperatures depended on primers) for 30 seconds. Multiplex genotyping strategies were used to confirm the results with TaqMan. The PCR for sequence analysis was performed using the Prime STAR™ HS (premix, TAKARA, Shiga, Japan) according to the manufacturer's protocol.

Ethics statement

The study was confirmed as a research activity qualifies as non-human participant by the Institutional Review Board of Seoul National University Hospital (No. 2018-001). All data were analyzed anonymously. The requirement for informed consent was waived by the board.

RESULTS

The results showed that 58% of the 200 SIDS cases were male infants (116 male and 84 female infants, respectively). In addition, the mean age was 140 days (median, 107 days; range, 24 to 270 days) and all the infants were of Asian ethnicity (Fig. 1). SIDS IA category criteria were fulfilled in 45 cases (22.5%) whereas the rest were determined to be SIDS IB (Table 2). All infants died in their sleep.
Fig. 1

Age and sex distribution of SIDS subjects.

SIDS = sudden infant death syndrome, M = male, F = female.

Table 2

Demographics, history, investigations, cardiac testing in 15 cases, which showed a genetic variant (R1193Q in SCN5A)

ID No.SexAge, dayPosition found at death sceneSIDS category
10M30SupineIA
14M31SupineIB
21M45SupineIA
28M53SupineIA
38M60SupineIB
59M65SupineIB
68M77SideIB
70M81ProneIB
99M103SupineIA
103M112SupineIB
105M118ProneIB
134F122SupineIB
137F143SupineIB
161M162SideIB
164F174SupineIA

SIDS = sudden infant death syndrome, M = male, F = female.

Age and sex distribution of SIDS subjects.

SIDS = sudden infant death syndrome, M = male, F = female. SIDS = sudden infant death syndrome, M = male, F = female. Table 1 shows the variants of LQTS-related genes detected in SIDS in this study. A previously reported SNP,122122 H558R in exon 12 and P1090L in exon 18 of the SCN5A gene was found in 36 and 9 (18.0% and 4.5%) SIDS cases, respectively. No variants indicating possible pathogenicity were found in this study. Fifteen cases (7.5%) had R1193Q in SCN5A (Table 1), which has been reported in association with LQTS and Brugada syndrome (BS),2223 but a recent study showed it to be a common polymorphism in Asians.12 The prevalence of the R1193Q mutation showed no statistical significance in relation to sex, SIDS category, and position of the infant at the death scene.

DISCUSSION

Although a molecular autopsy is not included as a standard protocol in SIDS cases, postmortem genetic testing is increasingly being recommended, especially focusing on arrhythmia syndrome.2425 Tester and Ackerman26 estimated that approximately 10% of all SIDS cases were actually caused by cardiac channelopathies resulting in LQTS. A previous large population-based study also reported that pathogenic variants associated with KCNH2 and SCN5A were found in 9.5% of subjects.18 From the start of this study, we cautiously selected category IA and IB SIDS cases and excluded those in category II to exclude the mechanical asphyxia and assess the precise relationship between SIDS and LQTS. We hypothesized that approximately 5%–10% of the pathogenic variants would be identified in this SIDS cohort. However, pathogenic variants associated with KCNQ1, SCN5A, KCNE1, KCNE2, KCNJ2, and CAV3 were not observed. In particular, detection of the R1193Q mutation in 15 cases was confusing. Previously, the R1193Q variant was reported in association with LQTS and BS.2122 This variant was present in 0.3%, 8%, and 12% of Caucasians, Asians,12 and the Han Chinese,22 respectively. Subsequently, the variant R1193Q was considered a common polymorphism in Asian populations.27 However, the influence of the R1193Q mutation in BS and LQTS currently remains unclear. The genetic risk might be polygenic and, thus, the R1193Q mutation in the SCN5A gene could influence variants of other genes, not previously reported.28 Routine analysis of LQTS-related genes in postmortem examination of SIDS cases has been recommended since channelopathies may be caused by pathogenic variants in genes associated with structural heart disease.29 However, a recent review reported that the overall diagnostic yield of gene variants in SIDS cases was substantially lower than that in the Exome Aggregation Consortium (ExAC) 14% vs. 41%, respectively.30 No significant differences were found between SIDS and ExAC yields for any genes. The New Zealand study also showed that no significant pathologic variants were found in the non-selected series of SIDS.28 In our study, the diagnostic rate of the pathological variants related to LQTS was zero, subsequently could raise the question as to whether a routine molecular autopsy associated with LQTS would be necessary for all cases of SIDS. The New Zealand study also showed few positive variants in SIDS study, which suggests that postmortem genetic testing in SIDS should be conducted in cases with a familial clinical history of sudden death or cardiac arrhythmia and the absence of risk factors such as a bed-sharing. Rare mutations associated with inherited cardiac diseases including LQTS, BS, and catecholaminergic polymorphic ventricular tachycardia (CPVT) could still explain more than 14% of SIDS cases.30 However, a molecular autopsy with large cohorts using next-generation sequencing (NGS) is still necessary. Forensic pathologists have established archives of formalin-fixed, paraffin-embedded (FFPE) tissue samples. Although molecular analysis using FFPE tissue samples has shown comparable quality,31 the cost of genetic testing has increased compared to the test using DNA extracted from blood. Presently, there is an urgent need to establish a national tissue (blood) bank for SIDS in Korea. Moreover, to elucidate the genetic risk associated with SIDS, simultaneous genetic testing of parents and siblings with a familial history of sudden death, syncope, and clinically proven arrhythmia would be reasonable, which is also effective for genetic counseling. However, in Korea, the decision to perform a medico-legal autopsy is made by public prosecutors, and the autopsy is typically performed if warranted, such as in suspicious deaths associated with a likely crime. Therefore, numerous cases of SUIDs were not pathologically investigated and no genetic counseling to prevent the sudden deaths of siblings has been established in Korea. Forensic molecular autopsy and valuable genetic counseling by clinicians should be performed to prevent SIDS. This study has some potential limitations that need to be considered. First, FFPE could cause DNA fragmentation, resulting in low DNA yields, which could increase the risk of allelic locus dropout.32 In this study, the DNA extraction and TaqMan SNP assays were performed in triplicate for all the point mutations, which were confirmed using sequence analysis. Second, recent studies used large gene panels investigated using NGS,3334 which would likely be a more promising method to discover the etiology of SIDS than other methods. However, there was no blood preservation for SIDS cases and, therefore, we had to analyze small panels of LQTS genes. Currently, we are preserving blood samples of SIDS cases to perform prospective studies using NGS to target all channelopathy-associated genes including those related to LQTS, Brugada, CPVT, and structural cardiac genes. Despite these limitations, this study has many strengths. For instance, to the best of our knowledge, this is the first report of genetic analysis in Korean SIDS. Most previous studies were conducted in Western countries.1011121314151617181920 Since other factors such as racial and environmental factors might be associated with SIDS, nationwide studies would have crucial implications. Second, this is the first study to focus on LQTS in SIDS in Korea. The collection of medico-legal autopsy data that provides the criteria for molecular autopsies in SIDS with clinical information including familial history for cardiac events is especially challenging in qualitative research in SIDS. In conclusion, only 15 of the 85 DNA variants tested from 6 genes involved in the LQTS exhibited R1193Q in SCN5A with doubtful pathogenicity, and no pathogenic variants were observed. Considering the diagnostic yield in this study was close to zero, these findings suggest that molecular autopsy should be cautiously conducted in select cases with a familial clinical history to improve the quality and availability of genetic counseling for the families of victims. Furthermore, other factors affecting the sudden death of vulnerable infants should be investigated through comprehensive autopsy examinations since the development of SIDS is complex and multifactorial. Moreover, it is necessary to establish a national young sudden death registry and investigative program including genetic counseling to explore the genetic background of inherited cardiac conditions including LQTS, BS, and CPVT as well as discover and assess genetic risk factors for SIDS in Korea.
  34 in total

Review 1.  The molecular autopsy: should the evaluation continue after the funeral?

Authors:  David J Tester; Michael J Ackerman
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

2.  SCN5A R1193Q polymorphism associated with progressive cardiac conduction defects and long QT syndrome in a Chinese family.

Authors:  A Sun; L Xu; S Wang; K Wang; W Huang; Y Wang; Y Zou; J Ge
Journal:  J Med Genet       Date:  2008-02       Impact factor: 6.318

Review 3.  Excavation of a buried treasure--DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues.

Authors:  R Klopfleisch; A T A Weiss; A D Gruber
Journal:  Histol Histopathol       Date:  2011-06       Impact factor: 2.303

4.  Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.

Authors:  M J Ackerman; B L Siu; W Q Sturner; D J Tester; C R Valdivia; J C Makielski; J A Towbin
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

5.  Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.

Authors:  Michael J Ackerman; Igor Splawski; Jonathan C Makielski; David J Tester; Melissa L Will; Katherine W Timothy; Mark T Keating; Gregg Jones; Monica Chadha; Christopher R Burrow; J Claiborne Stephens; Chuanbo Xu; Richard Judson; Mark E Curran
Journal:  Heart Rhythm       Date:  2004-11       Impact factor: 6.343

6.  Long QT syndrome and dilated cardiomyopathy with SCN5A p.R1193Q polymorphism: cardioverter-defibrillator implantation at 27 months.

Authors:  Hye Won Kwon; Sang Yoon Lee; Bo Sang Kwon; Gi Beom Kim; Eun Jung Bae; Woong Han Kim; Chung Il Noh; Sung Im Cho; Sung Sup Park
Journal:  Pacing Clin Electrophysiol       Date:  2012-04-22       Impact factor: 1.976

7.  KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties.

Authors:  Lee L Eckhardt; Amanda L Farley; Esther Rodriguez; Karen Ruwaldt; Daniel Hammill; David J Tester; Michael J Ackerman; Jonathan C Makielski
Journal:  Heart Rhythm       Date:  2006-11-10       Impact factor: 6.343

8.  Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation.

Authors:  Morten S Olesen; Bo H Bentzen; Jonas B Nielsen; Annette B Steffensen; Jens-Peter David; Javad Jabbari; Henrik K Jensen; Stig Haunsø; Jesper H Svendsen; Nicole Schmitt
Journal:  BMC Med Genet       Date:  2012-04-03       Impact factor: 2.103

Review 9.  Sudden infant death syndrome and inherited cardiac conditions.

Authors:  Alban-Elouen Baruteau; David J Tester; Jamie D Kapplinger; Michael J Ackerman; Elijah R Behr
Journal:  Nat Rev Cardiol       Date:  2017-09-07       Impact factor: 32.419

10.  Long QT molecular autopsy in sudden infant death syndrome.

Authors:  Joanna Moira Glengarry; Jackie Crawford; Paul Lowell Morrow; Simon Robert Stables; Donald Roy Love; Jonathan Robert Skinner
Journal:  Arch Dis Child       Date:  2014-03-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.